Compare OEC & CUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OEC | CUVL |
|---|---|---|
| Founded | 1862 | N/A |
| Country | Luxembourg | Australia |
| Employees | N/A | 16 |
| Industry | Major Chemicals | Miscellaneous |
| Sector | Industrials | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 397.0M | 374.2M |
| IPO Year | 2014 | N/A |
| Metric | OEC | CUVL |
|---|---|---|
| Price | $5.90 | $5.63 |
| Analyst Decision | Sell | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $6.56 | N/A |
| AVG Volume (30 Days) | ★ 344.7K | 22.8K |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | ★ 1.11% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,806,700,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.21 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.35 | $5.70 |
| 52 Week High | $8.64 | $8.20 |
| Indicator | OEC | CUVL |
|---|---|---|
| Relative Strength Index (RSI) | 45.19 | 34.38 |
| Support Level | $5.61 | N/A |
| Resistance Level | $6.57 | $6.07 |
| Average True Range (ATR) | 0.25 | 0.16 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 44.06 | 3.39 |
Orion SA is a manufacturer of carbon black products. Carbon black is a powdered form of carbon used to create the desired physical, electrical, and optical qualities of various materials. The company's operating segments are Specialty Carbon Black and Rubber Carbon Black. It generates maximum revenue from the Rubber Carbon Black segment. The Rubber Carbon Black segment is used in the reinforcement of rubber in tires and mechanical rubber goods. The Specialty Carbon Black segment is used as pigments and performance additives in coatings, polymers, printing, and special applications. Geographically, it derives a majority of its revenue from Germany.
Clinuvel distributes a single product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to light, affecting a patient's quality of life. Scenesse is a patented dissolvable implant, comparable in size with a rice grain, injected underneath the skin roughly every three months for ongoing protection. The implant controls the release of a synthetic drug which promotes the production of more melanin, thereby reducing pain and increasing tolerance for light exposure. The majority of Clinuvel's earnings stem from Europe and the US.